Article
Rapid spread in Norway of an erythromycin-resistant pneumococcal clone, despite low usage of macrolides.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2007
Sogstad Maren K R, Littauer Pia, Aaberge Ingeborg S, Caugant Dominique A, Høiby Arne
Abstract excerpt
During the last 4 years, Norway has experienced an increase in macrolide resistance among systemic isolates of Streptococcus pneumoniae. The Norwegian reference laboratory for pneumococci received the isolates from over 85% of the Norwegian cases of systemic pneumococcal disease in the period stu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
